Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


News In Brief

This article was originally published in The Gray Sheet

Executive Summary

GE Healthcare unveils Blueprint for low-dose CT imaging. Bard v. Gore litigation update. MedPAC chair calls for quicker move to accountable care. More news briefs.

You may also be interested in...

News In Brief

Bard scores a big win over Gore in a patent dispute. Medtronic announces the launch of a new sheath for its cryoballoon cardiac ablation system. Researchers publish a study on a novel esophageal probe. More news in brief.

Bard Acquires Neomend Amid Mixed Third Quarter Results

The deal, which has already closed, will “significantly expand” the business opportunities for Bard’s surgical specialties unit, the firm said.

Senate Panel Supports $56 Million Boost For NIH Translational Science Center

The National Center for Advancing Translational Sciences would get a sizable chunk of the funding increase approved for NIH by the Senate Appropriations Committee but support for increasing its budget is not universal.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts